11 April 2018
Sofosbuvir plus ribavirin and sofosbuvir plus daclatasvir-based regimens are suboptimal in genotype 2 patients: real-life experience from the Hepather ANRSCO22 cohort.
C. HEZODE, V. de LEDINGHEN, G. HAOUR, J.P. BRONOWICKI, F. ZOULIM, D. LARREY, S. METIVIER, A. TRAN, P. MARCELLIN, D. SAMUEL, O. CHAZOUILLERES, S. CHEVALIEZ C. DORIVAL, H. FONTAINE, J.-M. PAWLOTSKY, F. CARRAT, S. POL, on the behalf of the AFEF/ANRS study group. EASL
Efficacy and safety of Elbasvir/Grazoprevir in women infected with hepatitis C virus genotype 1 or 4 and co-administered oral contraceptives or hormone replacement therapy
C. HEZODE, P. KWO, J. SPERL, G. DORE, P. HWANG, J. LONG, R. TALWANI, M. ROBERTSON, B. HABER
Characteristics and retreatment of HCV DAA failure patients: Real-life experience.
I. RUIZ, S. FOURATI, A. VARAUT, G. SCOAZEC, M. FRANCOIS, M. WLASSOW, L. POITEAU, F. DONATI, A. SOULIER, S. CHEVALIEZ, A. MALLAT, J.-M. PAWLOTSKY, C. HEZODE
Short-term suvival after liver transplantation depends on the matching of graft and recipient caracteristics
E. LEVESQUE, E. AUDUREAU, A. WINTER, C. ANTOINE, J.P. DAURES, P. LANDAIS, D. AZOULAY, C. DUVOUX, C. FERAY, O. Group.
Rescue allocationin the french nationwide liver graft cohort
C. FERAY, A. WINTER, M. DISABATO, P. COMPAGNON, C. JACQUELINET, J.P. DAURES, D. AZOULAY, P. LANDAIS, O. Group.
Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance
M. ZIOL, N. POTE, G. AMADDEO, A. LAURENT, J.C. NAULT, F. OBERTI, C. COSTENTIN, S. MICHALAK, B. MOHAMED, C. FRANCOZ, G.-P. PAGEAUX, J. RAMOS, D. THOMAS, A. LUCIANI, B. GUIU, V. VILGRAIN, C. AUBE, J. DERMAN, C. CHARPY, J. ZUCMAN-ROSSI, N. BARGET, O. SEROR, N. GANNE-CARRIE, V. PARADIS, J. CALDERARO
Proof-of-concept of shotgun metagenomic sequencing as diagnostic tool for diagnosis of acute viral hepatitis.
I. RUIZ, G. GRICOURT, S. FOURATI, S. CHEVALIEZ, A. LE BOUTER, H. REGNAULT, V. DEMONTANT, F. LE GAL, E. GORDIEN, C. HEZODE, C. RODRIGUEZ, J.-M. PAWLOTSKY.
Longitudinal analysis of HCV full genomes in patients failing NS5Ainhibitors reveals the selection of novel amino acid substitutions outside NS5A
S. FOURATI, C. RODRIGUEZ, A. SOULIER, L. POITEAU, D. VANESSA, I. RUIZ, C. HEZODE, S. CHEVALIEZ, J.-M. PAWLOTSKY
Molecular diversity of HDV strains that spread in France: a study of 2224 clinical strains prospectively collected during fifteen years
A. GERBER, F. LE GAL, S. DZIRI, C. ALLOUI, D. ROULOT, Z. BEN ABDESSELAM, S. BRICHLER, E.GORDIEN
Molecular diversity of HBV and HDV amino-acid sequences involved in HDV virion morphogenesis according to HBV and HDV genotypes: study of 1590 clinical strains
A. GERBER, S. DZIRI, S. BRICHLER, C. ALLOUI, D. ROULOT, Z. BEN ABDESSELAM, F. LE GAL, E. GORDIEN
EASL - 11-15 avril 2018 - Paris
Précédent Toutes les actualités Suivant